XBiotech(XBIT) - 2022 Q3 - Quarterly Report
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended September 30, 2022 or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 British Columbia, Canada __ (State or other jurisdiction of incorporation or organization) (IRS Employer Identification No.) 5217 Winnebago Ln, Austin, TX 78744 (Address of principal executive off ...